Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Clonmel Healthcare Ltd. and Basf AS regarding Omega-3-acid ethyl ester medicines: dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors
Important Safety Information – Omega-3-acid ethyl ester medicines